KOSPIInsurance005830

DB Insurance

₩183,000▼ 0.05%2026-10-02 close

Market Cap

₩12T

Turnover

₩45.8B

Volume

250,000 shares

Shares out.

65.5M

PER

6.6×

PBR

0.9×

EPS

₩29,550

Dividend Yield

3.88%

PER, EPS, PBR and BPS are calculated in-house from the last 4 quarters (2025Q3–2026Q2) · Dividend yield is based on ₩7,600 per share · Prices as of the 2026-10-02 close

Report overview

Long-term insurance recovery meets auto underwriting losses

A rebound in long-term insurance earnings and actuarial assumption changes drove a sharp profit recovery in Q2 2026, even as loss-making auto insurance and the capital and integration burden from the Fortegra acquisition are being tested at the same time.

1
In Q2 2026 insurance revenue was KRW 4,270.1bn with operating profit of KRW 1,173.9bn and owners' net profit of KRW 875.9bn, a sharp rebound from the prior quarter's KRW 413.0bn operating profit and KRW 238.4bn net profit.
2
In its August 13, 2026 earnings release the company reported Q2 long-term insurance profit of KRW 510.5bn, up 98.6% year on year, attributing it to better long-term risk loss ratios and reversals of onerous contracts following actuarial assumption changes.
3
The same release showed Q2 auto insurance profit of just KRW 6.2bn, down 80.6% year on year, widening the gap between business lines.
4
A corporate value-up plan disclosed on August 28, 2026 raised the 2030 payout target to 40% on a consolidated and 50% on a separate basis and introduced a new Dividend Coverage Ratio (DCR) metric.
5
The USD 1.65bn acquisition of U.S. specialty insurer Fortegra closed at the end of May 2026, but the company reported its Q2 K-ICS ratio at 204.3%, down 27.8 percentage points from the prior quarter.

Business structure

DB Insurance is a full-line non-life insurer built on three pillars: long-term insurance, auto insurance and general (commercial) insurance.

In a May 26, 2026 credit opinion, Korea Investors Service described it as the country's second-largest non-life insurer by total assets and insurance revenue, with a diversified product portfolio and balanced distribution channels.

The same report noted a high market share in auto insurance and a top-tier position in long-term insurance. Earnings come from two engines, insurance service results and investment results; the company disclosed first-half insurance profit of KRW 788.4bn and Q2 investment profit of KRW 402.1bn on August 13, 2026.

The contractual service margin (CSM) balance, which represents the stock of future insurance profit, stood at KRW 12.8tn in Q2 2026 per company disclosure, similar to the level cited by Korea Investors Service as of end-March 2026.

Overseas operations span the United States, China and Southeast Asia; after buying stakes in Vietnam's VNI and BSH in 2024, the company completed a 100% acquisition of U.S. specialty insurer Fortegra on May 30, 2026.

Fortegra, founded in 1978 and headquartered in Jacksonville, Florida, writes specialty, credit and warranty insurance plus related services, and posted 2025 gross written premium and premium equivalents of USD 3.35bn with net profit of USD 160m, according to the company.

Domestically it competes for top-tier position with Samsung Fire & Marine, Hyundai Marine & Fire, KB Insurance and Meritz Fire & Marine, with channel competition over new long-term health policies and CSM accumulation continuing.

On ownership, Korea Investors Service noted that as of end-March 2026 chairman Kim Nam-ho held 9.74% and related parties together held 27.50%.

Earnings trend

Quarterly revenue · Operating profit

₩4.1T₩798.5B25Q2₩4.1T₩441.3B25Q3₩4.2T₩524.4B25Q4₩4.2T₩413B26Q1₩4.3T₩1.2T26Q2

RevenueOperating profit

Annual revenue · Operating profit

₩13.7T₩2.7T2022₩14.6T₩2.2T2023₩15.7T₩2.4T2024₩16.4T₩2.4T2025

RevenueOperating profit

Quarterly results · Last 5 quarters
Quarter	Revenue	Operating profit	Op. margin
2025Q2	₩4.1T	₩798.5B	19.7%
2025Q3	₩4.1T	₩441.3B	10.7%
2025Q4	₩4.2T	₩524.4B	12.4%
2026Q1	₩4.2T	₩413B	9.8%
2026Q2	₩4.3T	₩1.2T	27.5%

Annual results
Year	Revenue	Operating profit	Net income (parent)	Op. margin	ROE	Debt-to-equity
2022	₩13.7T	₩2.7T	₩2T	—	16.9%	375.4%
2023	₩14.6T	₩2.2T	₩1.7T	—	17.0%	482.7%
2024	₩15.7T	₩2.4T	₩1.9T	—	19.9%	608.2%
2025	₩16.4T	₩2.4T	₩1.8T	—	16.4%	576.9%

Consolidated basis (financial statements including subsidiaries) · Final figures from DART filings · Net income attributable to owners of the parent · Data as of 2026-09-04

Earnings analysis

Annual insurance revenue rose for four straight years, from KRW 13,692.5bn in 2022 to KRW 14,571.1bn in 2023, KRW 15,701.1bn in 2024 and KRW 16,432.6bn in 2025.

Operating profit, by contrast, fell from KRW 2,726.0bn in 2022 to KRW 2,235.0bn in 2023 before hovering around the mid-KRW 2tn range at KRW 2,424.9bn in 2024 and KRW 2,384.0bn in 2025, while owners' net profit moved from KRW 2,033.9bn in 2022 to KRW 1,738.6bn, KRW 1,851.6bn and KRW 1,788.0bn in the following three years.

Operating margin drifted down from 19.9% in 2022 to 15.3% in 2023, 15.4% in 2024 and 14.5% in 2025, showing that top-line growth did not fully translate into margin. Quarterly swings have been wide.

From KRW 798.5bn operating profit and KRW 650.4bn net profit in Q2 2025, results eased to KRW 441.3bn and KRW 328.2bn in Q3 2025 and KRW 524.4bn and KRW 378.6bn in Q4, then bottomed in Q1 2026 at KRW 413.0bn and KRW 238.4bn, an operating margin of 9.8%.

Q2 2026 then delivered KRW 4,270.1bn of insurance revenue, KRW 1,173.9bn of operating profit and KRW 875.9bn of owners' net profit, lifting the operating margin to 27.5%.

On August 13, 2026 the company attributed the rebound to improved long-term risk loss ratios together with reversals of onerous contracts after actuarial assumption changes, the latter being inherently non-recurring in nature.

The same release put Q2 auto insurance profit at KRW 6.2bn, down 80.6% year on year, while general insurance swung back to a KRW 45.1bn profit, underlining the divergence across lines.

On the balance sheet, equity shrank from KRW 12,124.3bn in 2022 to KRW 9,391.2bn in 2024 before recovering to KRW 10,935.3bn in 2025, while the liabilities-to-equity ratio rose from 375.4% to 608.2% and then eased to 576.9%; cash flow from operations turned negative at KRW -282.4bn in 2025 after large inflows in 2022-2024, a shift worth monitoring alongside insurance liability and investment flows.

Industry analysis

Korea's non-life insurance industry is dealing with auto underwriting losses and strained indemnity health loss ratios at the same time.

Data cited by Newsspace in July 2026 showed the industry's auto insurance line posting roughly KRW 189bn of operating losses in the first half of 2026, its first first-half deficit in six years since 2020, with the four largest insurers' cumulative loss ratio at 84.5%, up 1.9 percentage points year on year.

The Financial Supervisory Service said on September 2, 2026 that the industry's auto line had been loss-making in 2024, in 2025 and again in January-May 2026.

On indemnity health insurance, Dealsite reported in January 2026, citing the Korea Insurance Research Institute, that the combined risk loss ratio across first- to fourth-generation products had exceeded 119%, entrenching a structure where claims outrun premiums.

On the regulatory side, the so-called eight-week rule for minor auto injury claimants, applying to accidents occurring on or after September 10, 2026, is seen as the single biggest swing factor; the Korea Insurance Research Institute was reported to estimate a 2-3 percentage point improvement in auto loss ratios if the rule settles in.

The same report also flagged that workarounds such as grade-11 diagnoses or intensified treatment within eight weeks could limit the actual benefit. Other sector-wide variables discussed for 2026 include extension of the 1,200% commission rule, easier bancassurance limits and debate over surrender value reserve rules.

Because DB Insurance is a top-tier player with a large auto book, it is heavily exposed both to the upside from reform and to the downside from loss ratio deterioration, while in long-term insurance it said in August 2026 that it would prioritize profitability and persistency over sheer volume in CSM competition.

Outlook

In its August 13, 2026 earnings release the company listed its execution priorities for the second half: improving profitability across long-term, auto and general lines, optimizing the asset portfolio, strengthening asset-liability management, accelerating its AI transformation and stabilizing Fortegra governance.

The mid-to-long-term value-up plan disclosed on August 28, 2026 raised the 2030 total payout target to 40% consolidated and 50% separate, committed to annual dividend-per-share growth of at least 10% and formalized a cash-dividend-centered policy.

The plan introduces the Dividend Coverage Ratio, defined as distributable profit divided by expected dividends, and sets an implementation corridor of a 150-220% K-ICS ratio and 100-400% DCR, with safety thresholds at 180% and 200% respectively.

Management also said it would avoid excessive competition for new-business CSM and instead manage new sales volume and product mix against long-term cash flow and distributable profit projections.

In auto insurance, the key items to watch in the second half are how the eight-week rule effective September 10, 2026 and the revised future-treatment-cost framework applying from October 25, as reported by Asia Economy Daily on September 2, 2026, feed through to loss ratios.

Overseas, Fortegra's consolidation now starts to show up in full; Seoul Shinmun reported in April 2026 that Fortegra was expected to account for roughly 10% of consolidated net profit once the deal closed.

That said, Bloter reported in June 2026 that on a simple assumption of unchanged earnings the payback on the investment could take more than ten years, so integration results will take time to verify.

The outcome of indemnity health insurance reform and premium rate discussions remains another variable shaping the insurance earnings path from 2027 onward.

Valuation

PER

6.6×

PBR

0.9×

ROE

15.9%

EPS

₩29,550

BPS

₩225,165

Dividend per share

₩7,600

The price-to-earnings multiple sits in the single-digit range where large Korean non-life insurers have typically traded, and the share price stands below consolidated net assets attributable to owners.

Note that the price-to-book figure shown on screen can appear either below or above one times depending on the calculation basis used, so it is worth checking which basis is being displayed.

The dividend yield is above the KOSPI market average, and the August 28, 2026 commitment to raise dividends per share by at least 10% a year, together with the higher payout targets, will drive the direction of dividend-related metrics.

On earnings quality, the Q2 2026 profit surge included reversals of onerous contracts tied to actuarial assumption changes, so recurring earnings should be distinguished from one-off items when looking at any multiple.

As for sell-side views, Shinhan Securities said in an August 31, 2026 report that while a re-rating trigger was still absent the dividend floor had risen, raising its target price to KRW 245,000, and Daol Investment & Securities said in a September 2, 2026 report that it lifted its target to KRW 270,000 on improved dividend predictability. Those are the brokers' own views; this report presents no investment opinion or target price of its own.

PER, EPS, PBR and BPS are all calculated in-house (the same method as Naver and Toss) · Dividend yield = cash dividend per share from DART filings (supplemented by KRX) ÷ current price · As of 2026-09-04

Bull factors

Long-term insurance recovery plus regulatory reform

On August 13, 2026 the company said Q2 long-term insurance profit rose 98.6% year on year to KRW 510.5bn, citing improved long-term risk loss ratios. Confirmed results show operating profit expanding from KRW 413.0bn in Q1 2026 to KRW 1,173.9bn in Q2, lifting the operating margin from 9.8% to 27.5%.

In auto insurance, the eight-week rule applies to accidents from September 10, 2026, and the Korea Insurance Research Institute was reported to estimate a 2-3 percentage point loss ratio improvement if the rule takes hold. The key question is whether that room for improvement shows up in reported results.

Higher payout targets and a new distributable-profit metric

The value-up plan disclosed on August 28, 2026 raised the 2030 payout target to 40% consolidated and 50% separate and committed to at least 10% annual growth in dividends per share.

The company introduced the Dividend Coverage Ratio, distributable profit divided by expected dividends, as a new management metric alongside the K-ICS ratio to define its implementation corridor.

Etoday reported in late August 2026 that Samsung Securities called it the first domestic case of formally quantifying the gap between accounting profit and actual dividend resources. Greater predictability in dividend policy is a confirmed development.

Geographic and line diversification via Fortegra

The 100% acquisition of Fortegra, completed on May 30, 2026 for USD 1.65bn, is the first case of a Korean insurer taking control of a U.S. carrier.

According to the company, Fortegra writes specialty and credit/warranty insurance across the U.S. and 12 European countries and has sustained a combined ratio around 90% over an extended period.

Seoul Shinmun reported in April 2026 that Fortegra was expected to contribute roughly 10% of consolidated net profit once the deal closed. The move seeks to offset domestic growth stagnation from low birth rates and aging through geographic and product diversification.

Bear factors

Structurally loss-making auto book and weather risk

The company reported Q2 2026 auto insurance profit of just KRW 6.2bn, down 80.6% year on year.

The Financial Supervisory Service said on September 2, 2026 that the industry's auto line lost money in 2024, 2025 and January-May 2026, while the four largest insurers' first-half cumulative loss ratio of 84.5% exceeded the roughly 80% level generally cited as breakeven.

The Korea Insurance Research Institute was reported to find that repair cost per accident is rising structurally as vehicles get larger and carry more advanced safety equipment. Loss ratio volatility also remains given that typhoons and heavy rain concentrate in the second half.

Reliance on one-off items and stalled CSM growth

The company itself said the Q2 2026 profit surge included reversals of onerous contracts arising from actuarial assumption changes.

In its May 2026 credit opinion, Korea Investors Service noted a large KRW 2.1tn experience adjustment reflecting early application of expense guidelines, weaker persistency and expected-versus-actual losses.

The same report put the CSM balance at KRW 12.8tn as of end-March 2026, up 5.1% from year-end, a modest growth rate. Confirmed annual figures also show the operating margin easing from 19.9% in 2022 to 14.5% in 2025.

Post-deal capital burden and integration workload

The company put its Q2 2026 K-ICS ratio at 204.3%, down 27.8 percentage points from 232.1% in the prior quarter due to the Fortegra closing, explaining that required capital grew faster than available capital.

Bloter reported in June 2026 that the deal equalled 24.6% of shareholders' equity, implying a heavier capital management burden, and that payback could exceed ten years assuming current earnings persist.

In the same report, a Samsung Securities analyst noted that specialty insurance requires deep expertise, making retention of key staff and preservation of existing profitability critical. Catastrophe and loss ratio volatility in the U.S. market is also a newly added variable.

Risk factors

Regulation and policy

Auto insurance rates are compulsory-line pricing subject to policy conditions, and the real effect of the eight-week rule effective September 10, 2026 and the revised future-treatment-cost framework from October 25 is not yet verified.

Newspim reported in August 2026 that workarounds such as grade-11 diagnoses or intensive treatment within eight weeks could limit the benefit.

Indemnity health insurance reform, extension of the 1,200% commission rule and debate over surrender value reserves could affect earnings and distributable profit at the same time.

Investments and interest rates

In its May 2026 credit opinion, Korea Investors Service noted that an aggressive investment stance keeps safe assets below 20% of the portfolio and that domestic and overseas real estate exposures carry ongoing loss potential.

The same report put real estate project financing exposure at about KRW 4.8tn as of end-March 2026, or 9% of invested assets, with substandard-or-below assets reduced to KRW 33.6bn.

Confirmed financials show equity falling from KRW 12,124.3bn in 2022 to KRW 9,391.2bn in 2024 before recovering to KRW 10,935.3bn in 2025, illustrating capital volatility from rate and valuation factors. Swings in net assets also feed into distributable profit.

Overseas execution

Because Fortegra closed only at the end of May 2026, post-merger integration results have yet to accumulate in reported earnings.

Bloter reported in June 2026 that the U.S. insurance market is more competitive than Southeast Asia with greater loss ratio volatility from major natural catastrophes and inflation, and that U.S. subsidiary John Mullen & Co posted Q1 net profit of KRW 1.1bn, down 59.0% year on year.

Merger synergies at the Vietnamese subsidiaries and profitability in China also need to be tracked. Currency moves are a standing variable for consolidated earnings and capital.

What to watch next

From September 10, 2026
The eight-week rule for minor injury claimants starts applying to newly occurring accidents. Monthly auto loss ratio disclosures should be checked for whether actual improvement matches the 2-3 percentage point scenario cited by the Korea Insurance Research Institute.
October 25, 2026
As reported by Asia Economy Daily on September 2, 2026, future treatment costs for minor injury claimants shift to an objective assessment framework. The point to watch is whether the resulting claims cost savings show up in fourth-quarter loss ratios.
During November 2026
Third-quarter 2026 results are due. Key items include underlying earnings excluding the actuarial assumption effects that boosted Q2, long-term risk loss ratios, the CSM balance trend, Fortegra's consolidated contribution and any recovery in the K-ICS ratio.
January-February 2027
Full-year 2026 results and the year-end dividend decision will be disclosed. The checkpoints are whether the August 28, 2026 commitment to at least 10% annual dividend-per-share growth and a rising payout ratio is actually executed, and whether the DCR and K-ICS ratio stay above the company's stated safety thresholds.
First half of 2027
Conclusions on indemnity health insurance reform, auto premium rate adjustments and the direction of surrender value reserve rules should take shape. Because these changes affect both insurance earnings and distributable profit, the two metrics need to be read together.

Overall view

DB Insurance has passed through a phase where scale and margin diverged: insurance revenue grew steadily from KRW 13,692.5bn in 2022 to KRW 16,432.6bn in 2025, while operating profit hovered in the mid-KRW 2tn range and the operating margin eased from 19.9% to 14.5%.

Quarterly results bottomed in Q1 2026 at KRW 413.0bn operating profit and KRW 238.4bn net profit before rebounding sharply to KRW 1,173.9bn and KRW 875.9bn in Q2, which the company attributed to better long-term risk loss ratios together with reversals of onerous contracts from actuarial assumption changes.

The bull case rests on the long-term insurance recovery, the payout targets raised on August 28, 2026 alongside the new distributable-profit metric, and diversification by geography and line through Fortegra.

The bear case rests on auto insurance profit collapsing to KRW 6.2bn in Q2 on company figures amid continued industry-wide auto losses, the quality of earnings that lean on one-off items, and the 27.8 percentage point drop in the K-ICS ratio plus integration workload after the acquisition.

The swing of 2025 operating cash flow to KRW -282.4bn is another reason to examine the gap between profit and cash.

The sequence to verify from here is how the eight-week rule effective September 10 and the October 25 change to future treatment costs feed into loss ratios, the underlying run-rate in third-quarter results in November, and execution of the return policy through the year-end dividend in early 2027. This report is prepared for information purposes.

Sources

Korea Exchange (KRX) — Prices · Market Cap · Volume
FSS electronic disclosure system (DART) — Financial statements · Dividend filings

Show 18 more articles and sources

Report written 2026-09-05 · Data as of 2026-09-04

This content is AI analysis of market data and web search results, provided for information only. It is not a solicitation or recommendation to invest. Investment decisions and their consequences are the investor's own responsibility. Data may be delayed or contain errors.